Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder

Author:

Palmer Amanda M12ORCID,Toll Benjamin A134ORCID,Carpenter Matthew J134,Donny Eric C5ORCID,Hatsukami Dorothy K6ORCID,Rojewski Alana M14ORCID,Smith Tracy T34,Sofuoglu Mehmet7,Thrul Johannes89ORCID,Benowitz Neal L1011ORCID

Affiliation:

1. Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA

2. Department of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA

3. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA

4. Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA

5. Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC, USA

6. Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA

7. Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA

8. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA

9. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA

10. Clinical Pharmacology Research Program, Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA

11. Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA

Abstract

Abstract The introduction of alternative nicotine and tobacco products (such as e-cigarettes, heat-not-burn devices, nicotine pouches) warrants an updated framework from which to conceptualize tobacco use disorder (TUD). The following review provides considerations for TUD within the context of novel products. Historically, the tobacco industry falsely claimed that cigarettes were not addictive or harmful and that those who smoked simply chose to do so. This generated an inaccurate lay perception that smoking is a free or informed choice. Research on nicotine pharmacology demonstrates the powerful addictive potential of nicotine, which is shaped by dose, speed of delivery, and other constituents generated. In addition, non-pharmacologic reinforcers motivate and maintain tobacco use behaviors for both traditional cigarettes and novel products. The negative consequences of combustible tobacco use are well known; however, these outcomes may differ for alternative products. Strategies used for combustible product cessation may be adapted for novel products, and treatment recommendations for TUD should be made within the context of a harm reduction framework wherein alternative product use may be the desired outcome. Providers must therefore be willing to modify their perceptions of products and treatment recommendations accordingly. Better public health outcomes are accomplished through promotion of abstinence from combustible smoking. For those who cannot wean from nicotine entirely, switching to less risky modes of delivery might be a secondary goal, with an eventual aim of stopping use of the alternative product. Implications: Given the advent of novel, alternative tobacco products, tobacco use disorder (TUD) must be conceptualized within a contemporary framework that includes harm reduction and alternative outcomes. The unique contributions of nicotine pharmacology, non-pharmacologic reinforcers, and consequences of use can be used to inform treatments for TUD with the ultimate goal of improving the health of individuals who use tobacco.

Funder

National Institutes of Health

National Institute on Drug Abuse

National Cancer Institute

Hollings Cancer Center

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health

Reference79 articles.

1. Reports of the surgeon general;National Center for Chronic Disease P, Health Promotion Office on S, Health,2014

2. Tobacco product use and cessation indicators among adults—United States, 2018;Creamer;Morb Mortal Wkly Rep.,2019

3. An update on hardening: a qualitative review;Hughes;Nicotine Tob Res.,2020

4. Commonalities and differences across substance use disorders: Phenomenological and epidemiological aspects;Shmulewitz;Alcohol Clin Exp Res.,2015

5. Informed choice and the nanny state: learning from the tobacco industry;Hoek;Public Health.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3